When results are visible, trust in the program grows stronger
Always consult with your healthcare provider before combining shilajit with any prescription medications
Farxiga/Forxiga is not currently approved for weight loss as a standalone indication in non-diabetics, but the evidence is accumulating: Currently, if weight loss is the primary goal in a non-diabetic patient, GLP-1 agonists (semaglutide/Ozempic, tirzepatide/Mounjaro) produce substantially greater weight loss (1015% vs 24%)
GLP-1 and GIP receptors are also present in thyroid C-cells, and animal studies have indicated an increased risk of medullary thyroid carcinoma with GLP-1RA treatment [43]
these are often absent from research-grade COAs and represent a real sourcing gap
"For the longest time, I was using eating as an activity," the 29-year-old Texan told The Post